Insights
Search Results
Client Highlights
4.14.26
Wilson Sonsini Advises Special Committee of the Board in Globalstar's Acquisition by Amazon
On April 14, 2026, Amazon and Globalstar announced they have entered into a definitive merger agreement under which Amazon will acquire Globalstar, a leading mobile satellite services (MSS) operator, a pioneer in non-geostationary orbit (NGSO) satellites and D2D technology, and a provider of critical and emergency communications to customers around the world. Wilson Sonsini Goodrich & Rosati is representing the special committee of Globalstar’s board of directors on the transaction.
Client Highlights
2.17.26
Wilson Sonsini Advises nLIGHT on $201 Million Follow-On Offering
On February 5, 2026, nLIGHT, Inc., a leading provider of high-power lasers for mission-critical directed energy, optical sensing, and advanced manufacturing applications, closed an underwritten public offering of 3,977,273 shares of its common stock at a public offering price of $44.00 per share. In addition, on February 9, 2026, nLIGHT closed the sale of an additional 596,590 shares of its common stock, at the same public offering price, pursuant to the full exercise of the underwriters’ option to purchase additional shares. The aggregate gross proceeds from the offering was approximately $201 million, before deducting the underwriting discounts and commissions and estimated offering expenses. Wilson Sonsini Goodrich & Rosati advised nLIGHT on the transaction.
Client Highlights
10.21.25
Wilson Sonsini Advises Armada Acquisition Corp. II on $1 Billion Business Combination with Evernorth Holdings
On October 20, 2025, Armada Acquisition Corp II (Armada II), a publicly traded special purpose acquisition company, and Evernorth Holdings Inc. (Evernorth), a newly formed Nevada corporation focused on enabling institutional-scale adoption of XRP, announced that they have entered into a definitive business combination agreement through which Evernorth will become a publicly listed company. The transaction is expected to raise more than $1 billion in gross proceeds, establishing Evernorth as the largest public XRP-treasury company and a first-of-its-kind institutional vehicle built to accelerate XRP adoption. Investors include SBI, Ripple, Rippleworks, and leading digital-asset and fintech investors such as Pantera Capital, Kraken, and GSR, with participation from Ripple co-founder Chris Larsen. Upon closing, the combined company will operate under the Evernorth name and is expected to trade on Nasdaq under the ticker symbol “XRPN,” subject to applicable listing requirements and other customary closing conditions.
News Articles
6.05.25
2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights
4.30.25
Wilson Sonsini Advises Micron on $1.75 Billion Senior Notes Offering
On April 29, 2025, Micron Technology, Inc., completed its offering of (i) $500,000,000 aggregate principal amount of 5.65 percent senior notes due 2032 (the "2032 Notes") and (ii) $1,250,000,000 aggregate principal amount of 6.05 percent senior notes due 2035 (the "2035 Notes" and, together with the 2032 Notes, the "Notes"). Micron intends to use the net proceeds from the sale of the Notes to redeem its outstanding 4.185 percent Senior Notes due 2027 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.
Client Highlights
1.24.25
Wilson Sonsini Advises Micron on $1 Billion Senior Notes Offering
On January 16, 2025, Micron Technology, Inc., settled its offering of $1 billion aggregate principal amount of 5.80 percent senior notes due 2035. Micron intends to use the net proceeds from the sale of the notes to pay the redemption price of its outstanding 4.975 percent senior notes due 2026 and for general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Micron on the transaction.
The Wilson Sonsini team representing Micron includes:
The Wilson Sonsini team representing Micron includes:
Client Highlights
8.09.24
Wilson Sonsini Advises Recursion on Definitive Agreement with Exscientia
On August 8, 2024, Recursion and Exscientia announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Wilson Sonsini Goodrich & Rosati advised Recursion on the transaction.
News Articles
8.08.24
IFLR1000 Recognizes Wilson Sonsini Practices, Attorneys in 2024 Guide
In the 2024 edition of its annual guide, IFLR recognized Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors in the U.S. and China. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
News Articles
6.06.24
Wilson Sonsini Practices, Attorneys Named in 2024 Chambers USA Guide
Wilson Sonsini Goodrich & Rosati practices and attorneys were honored in the recently published 2024 edition of Chambers USA: America's Leading Lawyers for Business. This year, the firm was ranked in 36 geography-specific practice categories, while 79 attorneys were honored among the best in their fields.
Client Highlights
11.10.23
Wilson Sonsini Advises Alpine Immune Sciences on $150 Million Follow-on Public Offering
On November 6, 2023, Alpine Immune Sciences, Inc., a clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the pricing of its underwritten public offering of 8,800,000 shares of its common stock and pre-funded warrants to purchase up to 3,200,000 shares of its common stock, pursuant to its existing shelf registration statement. Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the transaction.
News Articles
8.01.23
Wilson Sonsini Practices and Attorneys Recognized in 2023 IFLR1000 Guide
In the recent 2023 edition of its annual guide, the IFLR1000 recognized numerous Wilson Sonsini practices and attorneys for their work in the financial and corporate sectors. The guide uses in-depth market analysis and interviews with practitioners and clients to determine leading financial and corporate law firms worldwide. Wilson Sonsini’s rankings are summarized below.
News Articles
6.01.23
2023 Chambers USA Guide Recognizes Wilson Sonsini Practices and Attorneys
The recently published 2023 edition of Chambers USA: America's Leading Lawyers for Business recognized numerous Wilson Sonsini Goodrich & Rosati practices and attorneys. This year, the firm was ranked in 35 geography-specific practice categories, while 79 attorneys were honored among the best in their fields.